Centanafadine Pharmaceutical Formulations, and Methods of Making and Using Same
Otsuka Pharmaceutical Co., Ltd.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 63/241,839, filed Sep 8, 2021. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,564,885 | Centanafadine Pharmaceutical Formulations, and Methods of Making and Using Same In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | ||
| US 11,759,426 | Centanafadine Pharmaceutical Formulations, and Methods of Making and Using Same In force · Low confidence | Otsuka Pharmaceutical Co., Ltd. | In force | Low confidence | ||
| US 11,980,690 | Centanafadine Pharmaceutical Formulations, and Methods of Making and Using Same In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | ||
| US 12,156,941 | Centanafadine Pharmaceutical Formulations, and Methods of Making and Using Same In force · Low confidence | Otsuka Pharmaceutical Co., Ltd. | In force | Low confidence | ||
| US 12,370,144 | Centanafadine Pharmaceutical Formulations, and Methods of Making and Using Same In force · Medium confidence | Otsuka Pharmaceutical Co., Ltd. | In force | Medium confidence | ||
| Application 19/249,883 | Centanafadine Pharmaceutical Formulations, and Methods of Making and Using Same Pending Not granted | Otsuka Pharmaceutical Co., Ltd. | Pending | Not granted |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Otsuka Pharmaceutical Co., Ltd..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.